Hepatotoxicity due to acetaminophen (APAP) overdose is a leading cause of drug-induced acute liver failure in clinic. Chlorogenic acid (CGA), a dietary polyphenol, was reported to prevent APAP-induced liver injury in our previous studies. This study aims to investigate the protection provided by CGA against APAP-induced hepatotoxicity via focusing on nuclear factor erythroid 2-related factor 2 (Nrf2) and extracellular regulated protein kinases (ERK)1/2. CGA prevented APAP-induced oxidative liver injury and enhanced Nrf2 activation in mice and in hepatocytes in vitro. CGA-provided the protection against APAP-induced hepatotoxicity was diminished after the application of Nrf2 siRNA in vitro and Nrf2 knockout mice in vivo. CGA enhanced the expression of heme oxygenase-1 (HO-1) and NAD(P)H: quinone oxidoreductase-1 (NQO1), and their inhibitors reduced the protection provided by CGA against APAP-induced cytotoxicity in hepatocytes. Molecular docking results indicated the potential interaction of CGA with Nrf2 binding site in Kelch-like ECH-associating protein-1 (Keap1). CGA decreased the expression of protein phosphatases including PP2A subunit A (PP2A-A) and PP5, and induced the sustained ERK1/2 phosphorylation. Moreover, ERK1/2 inhibitors (U0126 and PD98059) and ERK2 siRNA abrogated CGAinduced Nrf2 phosphorylation and its subsequent transcriptional activation, and also reduced the protection provided by CGA against APAP-induced cytotoxicity in hepatocytes. These results suggest that CGA protects against APAP-induced hepatotoxicity by activating Nrf2 antioxidative signaling pathway via blocking the binding of Nrf2 to its inhibitor protein Keap1, and ERK1/2 plays a critical role in regulating CGA-induced Nrf2 transcriptional activation. CGA is a promising therapeutic agent for the detoxification of APAP-induced hepatotoxicity.
cellular redox homeostasis (Zhang et al., 2010) . Keap1 is a cytosolic inhibitor for Nrf2; and disrupting the Nrf2-Keap1 interaction leads to the activation of Nrf2 (Shen and Kong, 2009; Zhang et al., 2010 ). It's clear that Nrf2-Keap1 plays important roles in the detoxification and elimination of potentially toxic exogenous chemicals or their metabolites (Shen and Kong, 2009; Zhang et al., 2010) . Nrf2-null mice have been reported to be highly susceptible to APAP-induced hepatotoxicity (Chan et al., 2001; Enomoto et al., 2001) , whereas Keap1-null mice were extremely resistant to APAP-induced liver injury (Okawa et al., 2006) .
Chlorogenic acid (CGA), a natural polyphenolic compound, is widely distributed in coffee, tea, medicinal plants and many fruits (Liang and Kitts, 2015) . CGA has well-known antioxidant and anti-inflammatory functions, and it is useful for the treatment of a variety of chronic diseases including diabetes, cardiovascular disease, neurological degeneration, and cancer (Heitman and Ingram, 2017; Liang and Kitts, 2015; Meng et al., 2013) . Moreover, CGA had a relatively high absorption rate (33%) in human small intestine (Olthof et al., 2001 ). Thus, it can be seen that dietary supplementary of CGA has health benefits. CGA has already been reported to have preventive and therapeutic detoxification against APAP-induced liver injury in our previous studies; liver GSH and thioredoxin (Trx) antioxidant system and nuclear factor jB (NFjB)-mediated inflammation are all involved in its detoxification (Ji et al., 2013; Zheng et al., 2015) . This study aims to further investigate the critical role of Nrf2 and ERK1/2 involved in the protection provided by CGA against APAP-induced hepatotoxicity.
MATERIALS AND METHODS
Chemicals and reagents. CGA (5-caffeoylquinic acid, CAS-327-97-9) with the purity ! 98% was purchased from Shanghai Hitsanns Co., Ltd (Shanghai, China). Kits for ALT/AST analysis were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Cignal Reporter Assay kit for Nrf2&Nrf1 and RNeasy Plus Mini kit were obtained from Qiagen (Hilden, German). Dual-Glo Luciferase Assay System was purchased from Promega (Madison, WI). Opti-MEM, 2 0 -7 0 -Dichlorodihydrofluorescein diacetate (H 2 DCFDA), lipofectamine RNAiMAX, lipofectamine 3000 were purchased from Life Technology (Carlsbad, CA). NE-PER nuclear and cytoplasmic extraction reagents and Pierce BCA Protein Assay Kits were purchased from ThermoFisher Scientific (Waltham, MA). Whole cell protein extraction and enhanced chemiluminescence kits were obtained from Millipore (Darmstadt, Germany). Antibodies for phospho-ERK1/2 (   202   Thr and   204 Tyr), total-ERK1/2, Actin, Lamin B1, LC3B, and Beclin 1 were purchased from Cell Signaling Technology (Danvers, MA). Antibodies for Nrf2, Keap1, HO-1, NQO1, and p62 were obtained from Santa Cruz (Santa Cruz, CA). Antibody for phospho-Nrf2 was purchased from GeneTax Inc. (Alton Parkway Irvine, CA). Peroxidase-conjugated goat anti-rabbit immunoglobulin G (IgG) (H þ L) and anti-mouse IgG (H þ L) were purchased from Jackson ImmunoResearch (West Grove, PA). PrimeScript RT Master Mix and SYBR Premix Ex Taq were obtained from Takara (Shiga, Japan). Control siRNA, ERK2 siRNA and Nrf2 siRNA were purchased from Santa Cruz (Santa Cruz, CA). Other reagents unless indicated were obtained from Sigma Chemical Co. (St. Louis, MO).
Cell culture. The L-02 cell line was derived from an adult human normal liver (Yeh et al., 1980 ) (Cell Bank, Type Culture Collection of Chinese Academy of Sciences, Shanghai). Cells were cultured in RPMI1640 supplemented with 10% [v/v] fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin. Experiments were performed on cells from passage 5 to 15.
Cell viability assay. Cells were pre-incubated with or without various inhibitors for 15 min, and then incubated with CGA for 15 min, and finally incubated with APAP or NAPQI for the indicated time. After treatments, cells were incubated with 500 lg/ml 3-(4,5-dimethyl-thiazol-2-yl) 2, 5-diphenyltetrazolium bromide (MTT) for 4 h. The formed blue formazan was dissolved in 10% SDS-5% iso-butanol-0.01 M HCl as described previously (Ji et al., 2009) , and the optical density was measured at 570 nm with 630 nm as a reference. Cell viability was normalized as the percentage of control.
Measurement of cellular and hepatic ROS. Cells were pre-incubated with H 2 DCFDA (20 lM) and CGA for 30 min, and then incubated with APAP for 24 h. Cellular ROS were measured as described in our previous published paper (Ji et al., 2009) . As for measuring hepatic ROS level, cold liver homogenate were centrifuged at 10 000 Â g (4 C). The supernatants were incubated with 10 lM H 2 DCFDA for 1 h, and then fluorescence was detected at excitation 485 6 20 nm, emission 525 6 20 nm by using a spectrophotometer (BioTek Synergy H4, Winooski, VT). Protein concentrations in supernatants were detected by using BCA kits. The results were calculated as units of fluorescence per microgram of protein and presented as the percentage of control.
Nrf2&Nrf1 luciferase reporter assay. Nrf2&Nrf1 luciferase reporter assay was performed as described in kits. Briefly, L-02 cells were transfected with Nrf2/1 transcription response element (TRE) containing construct by using Lipofectamine 3000. After 24 h of transfection, cells were pre-treated with CGA for 15 min, and then incubated with APAP for the additional indicated time. Luciferase activities were measured using the Dual-Glo Luciferase Assay System, and the constitutively expressed Renilla luciferase was used as an internal control.
Protein extraction. Cells were pre-incubated with CGA for 15 min, and then incubated with APAP for the additional indicated time. After treatment, cellular proteins were isolated using whole cell protein extraction kits. Cytosolic and nuclear proteins in cells or liver tissues were isolated as described in kits. The protein concentrations were measured, and all the samples in the same experiment were normalized to the equal protein concentration.
Western-blot analysis. Protein samples were separated by SDS-PAGE gel electrophoresis and transferred onto a PVDF membrane, and then incubated with the appropriate combination of primary and secondary antibodies. Proteins were visualized by using a chemiluminescent kit. The gray densities of the protein bands were normalized by using b-actin or Lamin B1 density as internal controls, and the results were further normalized to control.
siRNA transfection. For Western-blot analysis, control siRNA (no silencing), Nrf2 siRNA, and ERK2 siRNA were transfected into cells by using lipofectamine RNAiMAX. For cell viability assay, control siRNA, Nrf2 siRNA, and ERK2 siRNA were transfected into cells by using lipofectamine RNAiMAX. After 24 h of transfection, cells were pre-treated with CGA for 15 min, and then incubated with APAP for another 48 h, and surviving cells were determined. For luciferase assay, cells were transfected with Nrf2/1 TRE containing construct and siRNA by using Lipofectamine 3000. After 24 h of transfection, cells were pretreated with CGA for 15 min, and then incubated with APAP for additional 18 h.
Real-time PCR analysis. Cells were pre-incubated with CGA for 15 min, and then incubated with APAP for additional indicated time, and cellular total RNA was isolated by using RNeasy Plus Mini kits. Liver total RNA was extracted by using TRIZOL reagent. cDNA was synthesized and Real-time PCR was conducted as described in kits. Relative expression of target genes was normalized to GAPDH or Actin, analyzed by 2 ÀDDCt method and given as ratio compared with the control. The primer sequences are shown in the Table 1 .
Molecular docking analysis. Molecular docking analysis was performed as described in our previous study . The confirmation of CGA is generated using Comformational Search (MMFF94X force field) in MOE2013.
Experimental animals. Specific pathogen-free ICR and C57BL/6 mice (16-20 g body weight) were purchased from Shanghai Laboratory Animal Center of Chinese Academy of Science (Shanghai, China). Nrf2 knock-out (Nrf2
) C57BL/6 mice were generated by SiDanSai Biotechnology Inc. (Shanghai, China) by using transcription activator-like effector nucleases (TALEN) technology. A pair of TALEN constructs for Nrf2 knock-out were cloned into a mammalian expression vector pCMV-TALEN and capped, polyA-tailed mRNA for injection were produced using the Ambion mMessage mMachine kits. The C57BL/6 knock-out mice were produced by microinjecting TALEN mRNAs into fertilized eggs. The knock-out allele has been sequence validated to have 2 missing base pairs (GA, 346-347 of the ORF), causing a frameshift and an early stop. DNA isolated from tail biospies was used for genotyping. Western-blot was conducted to confirm the deletion of Nrf2 protein in mice (Supplementary Figure 1) .
The animals were supplied with standard laboratory diet and water ad libitum at a temperature of 22 6 1 C with a 12 h light-dark cycle (6:00-18:00) and 65 6 5% humidity. All animals received humane care in compliance with the institutional animal care guidelines approved by the Experimental Animal Ethical Committee, Shanghai University of Traditional Chinese Medicine.
Animal treatment. Sixty ICR male mice were randomly divided into 6 groups: (1) vehicle control, (2) APAP (300 mg/kg),
APAP þ CGA (40 mg/kg), and (6) CGA (40 mg/kg). Mice were orally pre-administered with CGA for 6 consecutive days. On the last day, mice were orally given with APAP at 1 h after CGA administration. Mice were sacrificed at 4 h after APAP intoxication, and plasma and liver tissue were collected. Thirty-two ICR male mice were randomly divided into 4 groups: (1) vehicle control, (2) APAP (300 mg/kg), (3) APAP þ CGA (20 mg/kg), and (4) APAP þ CGA (40 mg/kg). Mice were orally preadministered with CGA for 6 consecutive days. On the last day, mice were orally given with APAP at 1 h after CGA administration. Mice were sacrificed at 8 h after APAP intoxication, and plasma and liver tissue were collected. Nrf2 þ/þ and Nrf2 À/À C57BL/6 mice were randomly divided into 3 groups: (1) vehicle control, (2) APAP (300 mg/kg), and (3) APAP þCGA (40 mg/kg). Each group contains 6 mice (male and female in half). Mice were pre-administered with CGA for 6 consecutive days. On the last day, mice were orally given with APAP at 1 h after CGA administration. Mice were sacrificed at 6 h after APAP intoxication, and plasma and liver tissue were collected. Nrf2 þ/þ and Nrf2 À/À C57BL/6 male mice were randomly divided into 3 groups: (1) vehicle control, (2) APAP (300 mg/kg), and (3) APAP þCGA (40 mg/kg). Each group contains 6 mice. Mice were orally given with CGA at 1 h after APAP administration.
Mice were sacrificed at 6 h after APAP intoxication, and plasma and liver tissue were collected.
Analysis of serum ALT/AST activities. Blood samples were kept at room temperature for 2 h. Serum was collected after centrifugation at 840 Â g for 15 min. Serum ALT and AST activities were measured with kits according to the manufacturer's instructions.
Analysis of liver GSH amount. Liver GSH levels were determined according to our previously reported method (Liang et al., 2011) .
Histological evaluation. A piece of the liver was fixed in 10% phosphate buffered saline (PBS)-formalin solution and embedded in paraffin. Samples were sectioned and stained with hematoxylin-eosin (H&E) for further histological observation.
Statistical analysis. Data are expressed as the mean 6 standard error of the mean (SEM). Significant differences were determined by One-Way ANOVAs with LSD post hoc tests, and P < 0.05 is considered to be statistically significant.
RESULTS

CGA Reversed APAP-Induced Hepatotoxicity In Vitro
Human hepatic L-02 cells are commonly used in the studies about the hepatotoxicity induced by different hepatotoxicants (Hong et al., 2012; Huang et al., 2013; Ji et al., 2015) . As shown in Figure 1A , CGA reversed the decreased cell viability induced by APAP (10 mM) in L-02 cells in the concentration-dependent manner when cells were incubated with APAP for 24, 3, and 48 h. CGA (25 and 50 lM) also reversed the decreased cell viability induced by NAPQI (200 lM), a toxic APAP metabolite, in L-02 cells ( Figure 1B) . Further results demonstrated that CGA (50 lM) 
Nrf2 Was Critical for the Protection Provided by CGA Against APAP-Induced Hepatotoxicity
Results from the luciferase reporter assay showed that CGA (25 and 50 lM) enhanced Nrf1/2 transcriptional activation when cells were incubated with CGA and APAP for 18 h; and CGA (50 lM) also enhanced Nrf1/2 activation when cells were incubated with CGA and APAP for 24 h ( Figure 2A ). As shown in Figures 2B and 2C, CGA (25 and 50 lM) increased the expression of Nrf2 in nucleus when cells were incubated with CGA and APAP for 18 h. In order to evidence the involvement of Nrf2 in the protection provided by CGA against APAP-induced hepatotoxicity, Nrf2 siRNA was used to knock down Nrf2 expression in L-02 hepatocytes ( Figure 2D ). As shown in Figure 2E , Nrf2 siRNA reduced the elevated cell viability induced by CGA (25 and 50 lM) after APAP intoxication. However control siRNA had no such inhibition.
HO-1 and NQO1 Were Involved in the Protection Provided by CGA Against APAP-Induced Hepatotoxicity As shown in Figure 3A , APAP (7.5 mM) enhanced cellular mRNA expression of catalytic and modified subunits of glutamatecysteine ligase (GCLC and GCLM). CGA (50 lM) further enhanced APAP-induced increase in GCLC mRNA expression, but had no effect on GCLM. APAP (7.5 mM) decreased cellular mRNA expression of HO-1 and NQO1, and CGA (25 and 50 lM) reversed this decrease ( Figure 3A) . Furthermore, Protoporphyrin (ZnPP) and diminutol (Dim), HO-1 and NQO1 inhibitor, both reduced the protection provided by CGA against APAP-induced cytotoxicity in L-02 cells, but GCL inhibitor L -Buthionine-(S, R)-sulfoximine (BSO) had no inhibition ( Figure 3B ). Next, the results of Westernblot showed that CGA also reversed the decreased expression of HO-1 and further enhanced the increased expression of NQO1 induced by APAP (Figs. 3C-D) . Data in Figures 3E-F showed that CGA and APAP had no effect on the expression of Keap1. However, CGA (50 lM) reversed APAP-induced the decrease in p62 expression. As shown in Supplementary Figures 2A-C However, CGA had no obvious effects on the increased conversion of LC3B I to LC3B II and the enhanced expression of Beclin 1 induced by APAP. CGA alone also had no effects on the conversion of LC3B I to LC3B II and the expression of Beclin 1 in L-02 cells.
Results of Molecular Docking Analysis
The molecular docking analysis was conducted to detect the potential interaction of CGA with Keap1 kelch domain, which is the binding site for Nrf2 in Keap1 protein. The chemical structure of CGA is shown in Figure 4A . The docking mode of CGA in the biding site of Nrf2 in Keap1 protein is illustrated in Figure 4B (Front view) and Figure 4C (Top view). The 3-dimension ( Figure  4D ) and 2-dimension ( Figure 4E ) interaction-map showed that CGA formed 2 H-benzene interactions between the benzene rings of chromone with Arg415 and Ala556. Hydrophilic L-quinic acid is exposed outside, forming H-benzene interaction with Tyr525 and 2 different directional H-bond interactions with Arg415 and Gln530. These different directional interactions facilitated CGA anchored into the binding site of Nrf2 in Keap1.
The results of Supplementary Figures 3A-B showed that CGA (50 lM) alone induced the nuclear translocation of Nrf2 in L-02 cells after incubated with cells for 6 h. Moreover, CGA (50 lM) alone also enhanced cellular mRNA expression of GCLC, GCLM, HO-1, and NQO1 in L-02 cells when cells were incubated with CGA for 6 h (Supplementary Figure 3C) .
CGA Induced the Sustained ERK1/2 Phosphorylation In Vitro
As shown in Figures 5A and 5B, CGA (50 lM) enhanced the sustained phosphorylation of ERK1/2 (especially ERK2) when cells were incubated with CGA and APAP for 8, 12, and 18 h. ERK1/2 inhibitors, U0126 and PD98059, reduced the protection provided by CGA against APAP-induced cytotoxicity in L-02 cells ( Figure  5C ). ERK2 siRNA reduced cellular expression of ERK2 ( Figure 5D ). As compared with control siRNA, ERK2 siRNA further reduced the decreased cell viability induced by APAP ( Figure 5E ). Dephosphorylation of phosphorylated ERK1/2 plays an important role in regulating the magnitude and duration of its activation. Next, the effects of CGA on the expression of some protein phosphatases were observed. When cells were incubated with CGA and APAP for 12 h, CGA (50 lM) decreased the expression of PP2A subunit A (PP2A-A) and PP5, but not MKP3 (Figs. 5F-G).
CGA-Induced Sustained ERK1/2 Phosphorylation Was Critical for Nrf2 Activation
As shown in Figures 6A and 6B , CGA (50 lM) enhanced Nrf2 phosphorylation when cells were incubated with CGA and APAP for 18 h. But such increased Nrf2 phosphorylation was abrogated by U0126 and PD98059. Results from luciferase reporter assay showed that CGA-induced increase in Nrf2 transcriptional activation at the presence of APAP was diminished after cells were transfected with ERK2 siRNA ( Figure 6C ). Furthermore, CGA-induced increase in Nrf2 nuclear translocation was also blocked by U0126 and PD98059 (Figs. 6D and 6E ).
CGA Induced Nrf2 Activation and Prevented APAP-Induced Liver Injury in Mice
As shown in Figures 7A and 7B , CGA (20 and 40 mg/kg) reduced the elevated serum ALT and AST activities induced by APAP (300 mg/kg) when mice were sacrificed at both 4 and 8 h after APAP intoxication. CGA reduced APAP-induced the increase in hepatic ROS level after mice were treated with APAP for 8 h ( Figure 7C ). In addition, CGA reversed the decreased liver GSH levels induced by APAP when mice were treated with APAP for both 4 and 8 h ( Figure 7D) . Next, the results in Figures 7E and 7F showed that CGA enhanced the nuclear translocation of Nrf2 in livers from mice treated with APAP for both 4 and 8 h.
Nrf2 Was Critical for the Protection Provided by CGA Against APAPInduced Liver Injury in Mice
When CGA was pre-administrated to mice for 6 consecutive days before APAP intoxication, CGA reduced the elevated serum ALT/AST activities induced by APAP in wild-type Nrf2 þ/þ mice, but such inhibition was diminished in Nrf2 À/À knock-out mice Figure 8C ) demonstrated that APAP induced severe liver damage in wildtype Nrf2 þ/þ mice, indicated by intrahepatic hemorrhage, lymphocyte infiltrations and nuclear disappearance. After CGA treatment, these phenomena induced by APAP were all ameliorated in wild-type Nrf2 þ/þ mice. In Nrf2 À/À knock-out mice, APAP induced even more serious liver damage, indicated by lymphocyte infiltrations, nuclear disappearance and the destruction of liver structure. However, CGA had no protection against APAP-induced liver injury in Nrf2 À/À knock-out mice.
This result implies the important role of Nrf2 in the preventive detoxification of CGA against APAP-induced hepatotoxicity in mice.
Our previous study has demonstrated the therapeutic detoxification provided by CGA against APAP-induced liver injury . Next, whether Nrf2 was also critically involved in the therapeutic detoxification of CGA against APAPinduced liver injury was observed. When CGA was only orally given once to mice after APAP intoxication, CGA also reduced the elevated serum ALT/AST activities induced by APAP in wildtype Nrf2 þ/þ mice, but such inhibition was diminished in Nrf2
knock-out mice (Figs. 8D and 8E ). Liver H&E observation ( Figure 8F ) also evidenced the severe liver injury induced by APAP in wild-type Nrf2 þ/þ mice, and CGA ameliorated the liver injury induced by APAP in wild-type Nrf2 þ/þ mice. Moreover, APAP induced even more serious liver damage in Nrf2 À/À knockout mice, but CGA had no protection against APAP-induced liver injury in Nrf2 À/À knock-out mice. This result evidenced that Nrf2 was also critically involved in the therapeutic detoxification provided by CGA against APAP-induced hepatotoxicity in mice.
DISCUSSION
Our previous studies have already demonstrated the protection provided by CGA against APAP-induced liver injury (Ji et al., 2013; Pang et al., 2015; Zheng et al., 2015) . However, the concrete mechanism is still not fully elucidated. CGA is reported to have great antioxidant activity (Liang and Kitts, 2015) . In this study, we found that CGA reduced APAP-induced the increase in hepatic ROS level in vivo and in vitro (Figs. 1D and 7C) , and also reversed the decreased liver GSH content induced by APAP in mice ( Figure 7D ). All those results indicate that CGA can prevent APAP-induced liver oxidative injury. Next, we found that CGA induced Nrf2 transcriptional activation in vitro (Figs. 2A-C) and in vivo (Figs. 7E and 7F) . Further results showed that the protection provided by CGA against APAP-induced cytotoxicity was diminished in Nrf2 siRNA transfected hepatocytes ( Figure 2E) . Moreover, the preventive and therapeutic detoxification provided by CGA against APAP-induced liver injury in wild-type normal mice were both diminished in Nrf2 À/À knock-out mice (Figure 8 ). All those results demonstrated that Nrf2 was critical for the preventive and therapeutic detoxification provided by CGA against APAP-induced hepatotoxicity. The transcription factor Nrf2 is reported to regulate the expression of a variety of target genes, including HO-1, NQO1, GCLC and GCLM (Jaiswal, 2004) . HO-1 and NQO1 have already been reported to be involved in APAP-induced hepatotoxicity and PD98059 (20 lM) for 15 min, and then incubated with CGA for another 15 min, and then further incubated with APAP for 18 h. Nrf2 nuclear translocation was detected by immunoblotting, and b-actin and Lamin B1 were used as loading controls. The results represent at least 3 independent experiments. E, The quantitative densitometric analysis of Nrf2 (n ¼ 3-5). Data are shown as mean 6 SEM. *p < .05 versus control; # p < .05 versus APAP; (Chiu et al., 2002; Moffit et al., 2007) . Our results showed that CGA enhanced HO-1 and NQO1 expression, and HO-1 and NQO1 inhibitors abrogated the protection provided by CGA against APAP-induced hepatotoxicity in hepatocytes (Figs. 3A-D) . These results imply that the increased expression of HO-1 and NQO1 contributes to the protection provided by CGA against APAPinduced hepatotoxicity. GCL, constituted of GCLC and GCLM, is the rate-limiting enzyme for GSH biosynthesis, which is important for the detoxification of APAP (Griffith, 1999) . However, GCL inhibitor BSO had no inhibition on CGA-provided the protection against APAP-induced cytotoxicity in L-02 cells. Thus, we think that GCL may not be involved in the protection provided by CGA against APAP-induced hepatotoxicity. Although CGA had no effect on the expression of Keap1 protein, the molecular docking analysis demonstrated the potential interaction between CGA and the Nrf2 binding site in Keap1 (Figure 4) . Such interaction occupies the Nrf2 binding site and leads to the dissociation of Nrf2 from Keap1, and thus induces Nrf2 activation. This also may be the reason why CGA alone can induce Nrf2 activation and enhance the expression of Nrf2 downstream genes including GCLC, GCLM, HO-1, and NQO1 (Supplementary Figure 3) . In addition, CGA reversed the decreased expression of p62 protein induced by APAP (Figs. 3E and  3F) . A previous report has shown that p62 competes with Nrf2 for binding to Keap1 protein , so CGAinduced the increase in p62 expression may further contribute to the release of Nrf2 from Keap1. It is reported that p62 is also a target gene of Nrf2 (Jain et al., 2010) . So, we think that CGA may induce p62 expression by activating Nrf2, which further contributes to Nrf2 transcriptional activation, and thus forms a positive feedback loop. p62 is also an autophagy-specific substrate, and inhibiting autophagy will lead to the accumulation of p62 Figure 7 . CGA induced Nrf2 activation and attenuated APAP-induced liver injury in mice. A, Serum ALT and AST activities were detected at 4 h after APAP intoxication (n ¼ 8). B, Serum ALT and AST activities were detected at 8 h after APAP intoxication (n ¼ 8). C, Liver ROS level were detected at 8 h after APAP intoxication (n ¼ 8). D, Liver GSH level were detected at 4 and 8 h after APAP intoxication (n ¼ 8). E, Liver nuclear expression of Nrf2 in mice was detected at 4 h after APAP intoxication, and Lamin B1 was used as a loading control. The results represent 6 independent experiments. Below figure is the quantitative densitometric analysis of Nrf2 (n ¼ 6). F, Liver nuclear expression of Nrf2 in mice was detected at 8 h after APAP intoxication, and Lamin B1 was used as a loading control. The results represent 3 independent experiments. Below figure is the quantitative densitometric analysis of Nrf2 (n ¼ 3). Data are shown as mean 6 SEM. *p < .05, **p < .01, ***p < .001 versus control; # p < .05, ## p < .01 versus APAP. Figure 8 . Effects of CGA on APAP-induced liver injury in Nrf2 À/À knock-out mice. Serum ALT (A) and AST (B) activities were detected at 6 h after APAP intoxication when mice were pre-administrated with CGA for 6 consecutive days. C, Liver histological observation. Representative images from each experimental group are shown (original magnification, Â100). Serum ALT (D) and AST (E) activities were detected when mice were given with CGA at 1 h after APAP intoxication. F, Liver histological observation. Representative images from each experimental group are shown (original magnification, Â100). Data are shown as mean 6 SEM (n ¼ 6). **p < .01, ***p < .001 versus control; # p < .05, ## p < .01 versus APAP; && p < .01 versus Nrf2 þ/þ mice. . Next, we further observed whether CGA-provided the reversal of the decreased p62 expression induced by APAP in hepatocytes was due to its inhibition on autophagy. The results showed that CGA had no obvious effect on APAP-induced autophagy in L-02 cells, and CGA alone also had no effect on autophagy (Supplementary Figure 2) . APAP was found to induce autophagy, which was helpful for the removal of APAP-adducts and contributed to the protection against APAP-induced liver injury (Ni et al., 2016) . These above results also imply that CGA protected APAPinduced hepatotoxicity not by promoting autophagy. ERK1/2 is associated with a variety of cell functions, including proliferation, differentiation, senescence, apoptosis, and migration (Sun et al., 2015) . A previous study reported that ERK1/2 activation was helpful for the protection provided by insulinlike growth factor I against APAP-induced hepatotoxicity (Hwang et al., 2007) . However, another study showed the contribution of Cot/tpl2 (MAP3K8), which activates ERK1/2 signaling cascade, to APAP-induced liver injury (Sanz-Garcia et al., 2013) . Thus, it can be seen that the concrete role of ERK1/2 in APAPinduced hepatotoxicity is not clear. In this study, CGA induced the sustained phosphorylation of ERK1/2 at the presence of APAP (Figs. 5A and 5B). ERK1/2 inhibitors (PD98059 and U0126) abrogated CGA-provided the protection against APAP-induced hepatotoxicity, and ERK2 siRNA further aggravated APAPinduced cytotoxicity in hepatocytes (Figs. 5C-E). All these results imply that CGA-induced sustained ERK1/2 phosphorylation contributes to its protection against APAP-induced hepatotoxicity.
The dephosphorylation of phosphorylated mitogenactivated protein kinases (MAPKs) is critical for regulating the magnitude and duration of kinase activation, which is executed by MAPK phosphatases (MKPs) and other protein phosphatases such as PP2A and PP5 (Mkaddem et al., 2009; Owens and Keyse, 2007; Roskoski, 2012) . Further results showed that CGA reduced the expression of PP2A-A and PP5 (Figs. 5F and 5G), which shall contribute to the reduced dephosphorylation of ERK1/2 and thus lead to its sustained phosphorylation. MKP3, a cytoplasmic MKP, is the first MKP with absolute substrate specificity for ERKs (Kidger and Keyse, 2016) . However, CGA had no inhibition on MKP3 protein expression. It has been reported that the binding of ERK2 with MKP3 is necessary for inducing its phosphatase catalytic activity (Camps et al., 1998) . Whether CGA will interfere with the interaction of ERK2 with MKP3 needs further investigation.
Previous studies have shown that protein kinase C (PKC)-induced phosphorylation of Nrf2 at Ser40 promotes the dissociation of Nrf2 from Keap1, and leads to its nuclear translocation (Huang et al., 2002) . Nrf2 activator sulforaphane is reported to induce Nrf2 phosphorylation and enhance the expression of Nrf2 downstream antioxidant genes in mice (Jiang et al., 2014) . In this study, CGA induced the phosphorylation of Nrf2 at Ser40 at the presence of APAP, indicating that CGA also activated Nrf2 by inducing its phosphorylation. Some previous studies have already shown that ERK1/2-mediated Nrf2 phosphorylation played some roles in preventing liver oxidative stress injury (Choi et al., 2016; Moon et al., 2014) . In this study, we found that ERK1/2 inhibitors reduced CGA-induced Nrf2 phosphorylation and its subsequent nuclear translocation (Figs. 6A, 6B, 6D , and 6E). Moreover, ERK2 siRNA also abrogated CGA-induced Nrf2 transcriptional activation ( Figure 6C ). All those results imply that ERK1/2 phosphorylation contributes to Nrf2 phosphorylation and its subsequent transcriptional activation induced by CGA.
In conclusion, this study demonstrated that transcription factor Nrf2 and its downstream antioxidant enzymes including HO-1 and NQO1 played a critical role in regulating the preventive and therapeutic detoxification provided by CGA against APAP-induced liver injury. CGA activates Nrf2 by interacting with the Nrf2 binding site in Keap1 and inducing ERK1/ 2-mediated Nrf2 phosphorylation.
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